Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Gains from Investment Securities: 2013-2024

Historic Gains from Investment Securities for Surgery Partners (SGRY) over the last 11 years, with FY2024 value amounting to $24.8 million.

  • Surgery Partners' Gains from Investment Securities rose 33571.43% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $42.2 million, marking a year-over-year increase of 4911.66%. This contributed to the annual value of $24.8 million for FY2024, which is 5069.58% down from last year.
  • Latest data reveals that Surgery Partners reported Gains from Investment Securities of $24.8 million as of FY2024, which was down 5069.58% from $50.3 million recorded in FY2023.
  • In the past 5 years, Surgery Partners' Gains from Investment Securities ranged from a high of $95.1 million in FY2022 and a low of $1.5 million during FY2021
  • Its 5-year average for Gains from Investment Securities is $34.7 million, with a median of $24.8 million in 2024.
  • As far as peak fluctuations go, Surgery Partners' Gains from Investment Securities skyrocketed by 624000.0% in 2022, and later tumbled by 5069.58% in 2024.
  • Surgery Partners' Gains from Investment Securities (Annual) stood at $1.7 million in 2020, then fell by 11.76% to $1.5 million in 2021, then skyrocketed by 6240.0% to $95.1 million in 2022, then crashed by 47.11% to $50.3 million in 2023, then crashed by 50.7% to $24.8 million in 2024.
  • Its Gains from Investment Securities stands at $24.8 million for FY2024, versus $50.3 million for FY2023 and $95.1 million for FY2022.